- Home
- AXSM vs LOPE Comparison
AXSM vs LOPE Comparison
Compare AXSM & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | LOPE |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 4.6B |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AXSM | LOPE |
|---|---|---|
| Price | $153.31 | $165.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 2 |
| Target Price | $176.00 | ★ $220.00 |
| AVG Volume (30 Days) | ★ 479.4K | 436.1K |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.46 |
| Revenue | $561,263,000.00 | ★ $1,090,524,000.00 |
| Revenue This Year | $66.20 | $9.20 |
| Revenue Next Year | $57.56 | $6.83 |
| P/E Ratio | ★ N/A | $22.24 |
| Revenue Growth | ★ 65.83 | 7.05 |
| 52 Week Low | $75.56 | $149.83 |
| 52 Week High | $154.49 | $223.04 |
Technical Indicators
Market Signals| Indicator | AXSM | LOPE |
|---|---|---|
| Relative Strength Index (RSI) | 64.08 | 52.85 |
| Support Level | $145.07 | $158.98 |
| Resistance Level | $149.13 | $158.67 |
| Average True Range (ATR) | 4.48 | 4.43 |
| MACD | -0.35 | 2.84 |
| Stochastic Oscillator | 94.96 | 92.47 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LOPE Grand Canyon Education Inc.
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges both online, on the ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.